OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours
Seval Beykan Schürrle, Uta Eberlein, C. Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2428-2441
Open Access | Times Cited: 5
Seval Beykan Schürrle, Uta Eberlein, C. Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2428-2441
Open Access | Times Cited: 5
Showing 5 citing articles:
Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting
Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 4049-4061
Open Access | Times Cited: 7
Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 4049-4061
Open Access | Times Cited: 7
Comparison of the tolerability of terbium-161 and lutetium-177 in combination with somatostatin analogues in the preclinical setting
Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Toxicity manifestations encountered in peptide receptor radionuclide therapy setting
Rahul V. Parghane, Sandip Basu
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Rahul V. Parghane, Sandip Basu
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours
Jelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Jelka Kuiper, Eline Zoetelief, Tessa Brabander, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Theranostics: Timing is Everything
J. Harvey Turner
Cancer Biotherapy and Radiopharmaceuticals (2024) Vol. 39, Iss. 9, pp. 611-618
Closed Access | Times Cited: 2
J. Harvey Turner
Cancer Biotherapy and Radiopharmaceuticals (2024) Vol. 39, Iss. 9, pp. 611-618
Closed Access | Times Cited: 2
